Back

Safety and quality of life assessment at 6 months follow-up of the valvosoft pivotal study.

31 August 2024 (09:00 - 09:30)
Organised by: Logo
Congress Presentation Part of: TAVI vs. SAVR: still unresolved question? Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Marleen van Wely

University Hospital Nijmegen, Nijmegen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Transcatheter versus surgical aortic valve replacement in lower-risk patients: an updated meta-analysis of randomised controlled trials
Doctor R. Reddy (Durham, US)
Abstract Slides Video
Presentation thumbnail
Incidence of aortic valve reintervention in patients with aortic stenosis undergoing TAVI vs SAVR: A systematic review and meta-analysis of randomised controlled trials
Miss J. Groberio (Vitoria, BR)
Abstract Slides Video
Presentation thumbnail
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients requiring mechanical circulation support: a nationwide Japanese study
Doctor K. Mitsui (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Transcatheter aortic valve implantation in failed bioprosthetic or native valves: a systematic review and meta analysis
Doctor R. Kaddoura (Doha, QA)
Abstract Slides Video
Presentation thumbnail
Unlocking the future: machine learning models for predicting in-hospital mortality after transcatheter aortic valve replacement: a single-arm meta-analysis
Doctor H. Ahmed (Omaha, US)
Abstract Slides Video

Access the full session

Session thumbnail
TAVI vs. SAVR: still unresolved question?

The Event

Event poster

ESC Congress 2024

31 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Percutaneous shockwave therapy for calcific aortic stenosis: a new kid on the block?
thumbnail
Congress Session
Late Breaking Clinical Science: management of aortic stenosis
thumbnail
Congress Session
Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources